1518PPembrolizumab frontline monotherapy in patients with...

Annals of Oncology 2019 / 10 Vol. 30; Iss. Supplement

1518PPembrolizumab frontline monotherapy in patients with NSCLC and high PD-L1 expression: Real-world data from a European Cohort with focus on subgroups of interest

Mountzios, G, Signorelli, D, Cobo, J Rey, Banini, M, Economopoulou, P, Russo, G Lo, Baxevanos, P T, Roila, F, de Toma, A, Banna, G, Christopoulou, A, Jimenez, B, Linardou, H, Calles, A, Galetta, D, Ad
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz260.040
Date:
October, 2019
File:
PDF, 92 KB
2019
Conversion to is in progress
Conversion to is failed